These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

308 related articles for article (PubMed ID: 36549296)

  • 61. Treatment of NAFLD with intermittent calorie restriction or low-carb high-fat diet - a randomised controlled trial.
    Holmer M; Lindqvist C; Petersson S; Moshtaghi-Svensson J; Tillander V; Brismar TB; Hagström H; Stål P
    JHEP Rep; 2021 Jun; 3(3):100256. PubMed ID: 33898960
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Low-fasting triglyceride levels are associated with non-invasive markers of advanced liver fibrosis among adults in the United States.
    Jiang ZG; Tsugawa Y; Tapper EB; Lai M; Afdhal N; Robson SC; Mukamal KJ
    Aliment Pharmacol Ther; 2015 Jul; 42(1):106-16. PubMed ID: 25913437
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Effect of enforced physical inactivity induced by 60-day of bed rest on hepatic markers of NAFLD in healthy normal-weight women.
    Rudwill F; Bergouignan A; Gastebois C; Gauquelin-Koch G; Lefai E; Blanc S; Simon C
    Liver Int; 2015 Jun; 35(6):1700-6. PubMed ID: 25413107
    [TBL] [Abstract][Full Text] [Related]  

  • 64. The role of liver fat and insulin resistance as determinants of plasma aminotransferase elevation in nonalcoholic fatty liver disease.
    Maximos M; Bril F; Portillo Sanchez P; Lomonaco R; Orsak B; Biernacki D; Suman A; Weber M; Cusi K
    Hepatology; 2015 Jan; 61(1):153-60. PubMed ID: 25145475
    [TBL] [Abstract][Full Text] [Related]  

  • 65. [Effects of aerobic exercise on CNPY2-PERK pathway in the liver of mice with non-alcoholic fatty liver disease].
    Li JH; Xiong W; Wang JQ; Li YL; Jiang CJ
    Zhongguo Ying Yong Sheng Li Xue Za Zhi; 2022 Sep; 38(3):193-198. PubMed ID: 36062783
    [No Abstract]   [Full Text] [Related]  

  • 66. Eating behavior traits of successful weight losers during 12 months of alternate-day fasting: An exploratory analysis of a randomized controlled trial.
    Kroeger CM; Trepanowski JF; Klempel MC; Barnosky A; Bhutani S; Gabel K; Varady KA
    Nutr Health; 2018 Mar; 24(1):5-10. PubMed ID: 29353535
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Metabolic inflexibility and insulin resistance in obese adolescents with non-alcoholic fatty liver disease.
    Lee S; Rivera-Vega M; Alsayed HM; Boesch C; Libman I
    Pediatr Diabetes; 2015 May; 16(3):211-8. PubMed ID: 24754380
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Impact of a structured lifestyle programme on patients with metabolic syndrome complicated by non-alcoholic fatty liver disease.
    Konerman MA; Walden P; Joseph M; Jackson EA; Lok AS; Rubenfire M
    Aliment Pharmacol Ther; 2019 Feb; 49(3):296-307. PubMed ID: 30561027
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Alternate-day fasting prevents non-alcoholic fatty liver disease and working memory impairment in diet-induced obese mice.
    Zhang W; Wang J; Wang L; Shi R; Chu C; Shi Z; Liu P; Li Y; Liu X; Liu Z
    J Nutr Biochem; 2022 Dec; 110():109146. PubMed ID: 36049672
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Treating NAFLD in OLETF rats with vigorous-intensity interval exercise training.
    Linden MA; Fletcher JA; Morris EM; Meers GM; Laughlin MH; Booth FW; Sowers JR; Ibdah JA; Thyfault JP; Rector RS
    Med Sci Sports Exerc; 2015 Mar; 47(3):556-67. PubMed ID: 24983336
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Changes in subjective measures of appetite during 6 months of alternate day fasting with a low carbohydrate diet.
    Kalam F; Gabel K; Cienfuegos S; Wiseman E; Ezpeleta M; Pavlou V; Varady KA
    Clin Nutr ESPEN; 2021 Feb; 41():417-422. PubMed ID: 33487299
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Gender Differences in Liver Steatosis and Fibrosis in Overweight and Obese Patients with Metabolic Dysfunction-Associated Steatotic Liver Disease before and after 8 Weeks of Very Low-Calorie Ketogenic Diet.
    Rinaldi R; De Nucci S; Donghia R; Donvito R; Cerabino N; Di Chito M; Penza A; Mongelli FP; Shahini E; Zappimbulso M; Pesole PL; Coletta S; Triggiani V; Cozzolongo R; Giannelli G; De Pergola G
    Nutrients; 2024 May; 16(10):. PubMed ID: 38794646
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Effect of Different Exercise Methods on Non-Alcoholic Fatty Liver Disease: A Meta-Analysis and Meta-Regression.
    Xiong Y; Peng Q; Cao C; Xu Z; Zhang B
    Int J Environ Res Public Health; 2021 Mar; 18(6):. PubMed ID: 33801028
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Randomized trial comparing effects of weight loss by liraglutide with lifestyle modification in non-alcoholic fatty liver disease.
    Khoo J; Hsiang JC; Taneja R; Koo SH; Soon GH; Kam CJ; Law NM; Ang TL
    Liver Int; 2019 May; 39(5):941-949. PubMed ID: 30721572
    [TBL] [Abstract][Full Text] [Related]  

  • 75. The effect of exercise training on intrahepatic triglyceride and hepatic insulin sensitivity: a systematic review and meta-analysis.
    Sargeant JA; Gray LJ; Bodicoat DH; Willis SA; Stensel DJ; Nimmo MA; Aithal GP; King JA
    Obes Rev; 2018 Oct; 19(10):1446-1459. PubMed ID: 30092609
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Effect of resistance training on non-alcoholic fatty-liver disease a randomized-clinical trial.
    Zelber-Sagi S; Buch A; Yeshua H; Vaisman N; Webb M; Harari G; Kis O; Fliss-Isakov N; Izkhakov E; Halpern Z; Santo E; Oren R; Shibolet O
    World J Gastroenterol; 2014 Apr; 20(15):4382-92. PubMed ID: 24764677
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Dissociation between exercise-induced reduction in liver fat and changes in hepatic and peripheral glucose homoeostasis in obese patients with non-alcoholic fatty liver disease.
    Cuthbertson DJ; Shojaee-Moradie F; Sprung VS; Jones H; Pugh CJ; Richardson P; Kemp GJ; Barrett M; Jackson NC; Thomas EL; Bell JD; Umpleby AM
    Clin Sci (Lond); 2016 Jan; 130(2):93-104. PubMed ID: 26424731
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Effect of Exercise on NAFLD and Its Risk Factors: Comparison of Moderate versus Low Intensity Exercise.
    Nath P; Panigrahi MK; Sahu MK; Narayan J; Sahoo RK; Patra AA; Jena S; Patnaik AK; Jena A; Singh SP
    J Clin Transl Hepatol; 2020 Jun; 8(2):120-126. PubMed ID: 32832391
    [No Abstract]   [Full Text] [Related]  

  • 79. Treatment of non-alcoholic fatty liver disease with metformin versus lifestyle intervention in insulin-resistant adolescents.
    Nadeau KJ; Ehlers LB; Zeitler PS; Love-Osborne K
    Pediatr Diabetes; 2009 Feb; 10(1):5-13. PubMed ID: 18721166
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Physical activity intervention for non-diabetic patients with non-alcoholic fatty liver disease: a meta-analysis of randomized controlled trials.
    Wang ST; Zheng J; Peng HW; Cai XL; Pan XT; Li HQ; Hong QZ; Peng XE
    BMC Gastroenterol; 2020 Mar; 20(1):66. PubMed ID: 32164541
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 16.